Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg Street 1, D-30625 Hannover, Germany.
Europace. 2014 Apr;16(4):604-11. doi: 10.1093/europace/eut222. Epub 2013 Aug 8.
The antimicrobial treatment of pacemaker casings with antiseptics (povidone-iodine or octenidine dihydrochloride) or antibiotics (vancomycin, daptomycin, cefuroxime, Tazobac, or nebacetin) was analysed in vitro for its biocompatibility and efficacy in preventing the bacterial adhesion of Staphylococcus epidermidis, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli to cardiac-implantable electrophysiological devices (CIEDs).
Titan platelets (0.4 cm²) cut from pacemaker casings were impregnated with seven different antimicrobial solutions: two antiseptics and five antibiotics. Subsequently, they were challenged with bacterial contamination by four test strains over a 24 h incubation period. Bacterial adherence was quantified using the colony-forming-unit method after cell recovery with sonication and examined with confocal laser scanning electron microscopy. Simultaneously, the biocompatibility of the antimicrobial impregnation was assessed using pre-treated titan platelets in a culture of human fibroblasts, skeletal myoblasts, and microvascular endothelial cells. After a 48 h incubation, cell vitality was measured using the 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H/tetrazolium monosodium (WST-8) assay. The immersion of pacemaker casings in antiseptic or antibiotic solutions applies an antimicrobial coating that can significantly reduce bacterial adhesion. The studied impregnations differed in their antimicrobial efficacy and toxicity.
Compared with the two antiseptics and the other tested antibiotics, nebacetin showed the best ratio of efficacy to toxicity. Nebacetin showed good in vitro antibacterial activity against both Gram-positive and Gram-negative pathogens without impairing human cell vitality. It is a safe and effective candidate for CIED impregnation.
分析了将防腐剂(聚维酮碘或奥替尼啶二盐酸盐)或抗生素(万古霉素、达托霉素、头孢呋辛、他唑巴坦或萘替芬)用于心脏植入式电生理设备(CIED)的起搏器外壳的抗菌处理,以评估其在预防表皮葡萄球菌、金黄色葡萄球菌、铜绿假单胞菌和大肠杆菌与心脏植入式电生理设备粘附方面的生物相容性和疗效。
从起搏器外壳上切割的钛血小板(0.4 cm²)用七种不同的抗菌溶液浸渍:两种防腐剂和五种抗生素。随后,将它们在 24 小时孵育期间用四种测试菌株进行细菌污染挑战。使用超声细胞回收后通过集落形成单位法量化细菌粘附,并使用共聚焦激光扫描电子显微镜检查。同时,使用预处理的钛血小板在人成纤维细胞、骨骼肌母细胞和微血管内皮细胞的培养物中评估了抗菌浸渍的生物相容性。孵育 48 小时后,使用 2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-二磺基苯基)-2H/四唑单钠盐(WST-8)测定法测量细胞活力。将起搏器外壳浸入防腐剂或抗生素溶液中会应用抗菌涂层,可显著减少细菌粘附。研究的浸渍在抗菌效果和毒性方面存在差异。
与两种防腐剂和其他测试的抗生素相比,奈替芬表现出最佳的疗效与毒性比。奈替芬对革兰氏阳性和革兰氏阴性病原体均具有良好的体外抗菌活性,且不损害人类细胞活力。它是一种安全有效的 CIED 浸渍候选物。